FDA Approved: KEPPRA XR — Original Application (UCB, Inc.)

View source ↗

Summary

The FDA approved KEPPRA XR (levetiracetam) under an original NDA from UCB, Inc., introducing an extended-release formulation of Keppra for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• KEPPRA XR (levetiracetam)

Snippet

ORIG AP for KEPPRA XR (LEVETIRACETAM)